H|T: The Healthtech Times – How Y Combinator decides which health care startups are worth a shot
Plus: Silofit closes its doors, VoxNeuro raises $4.5M to scale brain performance.
Healthtech
Canadian startup struggles continue as Silofit closes up shop, Top Hat and Fable cut staff
Trio joins growing list of Canadian tech firms that have restructured or ceased operating during the downturn.
H|T: The Healthtech Times – Turnstone Biologics goes public, Dialogue Health to be acquired
Plus: Vital Bioscience reveals desktop blood tester with big backers.
H|T: The Healthtech Times – Ora Medical gets the BDC Bump
Plus: Halifax’s 3D BioFibR secures $3.52M for automated collagen fibre manufacturing.
Vital Biosciences reveals desktop blood-testing device with funding from OpenAI, Salesforce CEOs
After the bloody mess at Theranos, Vital is among the new wave of startups developing accessible diagnostics.
Sun Life Canada to acquire Dialogue Health Technologies
Dialogue will maintain its head office in Montréal and operate as a standalone entity as part of Sun Life Canada.
Practice Better acquires That Clean Life for a healthy-sounding eight figures to continue expansion
An eight-year collaboration has ended in acquisition for the two Toronto healthtech startups.
Ontario organizations secure nearly $20 million in federal funds to drive entrepreneurship, job creation
Funding is split between five companies and one business hub in Toronto, as well as one Ottawa-based firm.
3D BioFibR secures $3.52 million in seed funding for automated collagen fibre manufacturing
3D BioFibR’s collagen fibre can be used as an artificial tendon in soft tissue repair research.
H|T: The Healthtech Times – Recursion secures $50M from Nvidia following Canadian drug-discovery acquisitions
Plus: Ditch Labs wants to treat nicotine addiction with tech.
H|T: The Healthtech Times – Spotify CEO’s Neko Health gets some big-name backers
Plus: There’s a $10M bounty to integrate AI into food production.
Well Health adds anesthesia subsidiary CarePlus Management in its latest acquisition
Well Health revised its annual revenue guidance sharply upwards after the purchase for an undisclosed sum.
After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for AI drug discovery
The US biotech firm opened a new Canadian HQ in Toronto last month.
Ditch Labs secures $3.25 million to treat nicotine addiction with tech
Montréal startup set its sights on a massive public health issue.